ClinicalTrials.gg
CompletedNCT05515679BRAINUpdated Mar 13, 2024Results posted

The BRAIN App: Building Relationships Using Artificial Intelligence and Nostalgia

An interventional study of The BRAIN App in Dementia, Dementia, Vascular and Alzheimer Disease, sponsored by Hopeful Aging. Completed at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2024-03-13.

Sponsored by Hopeful Aging · Not applicable, Interventional, and Treatment

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
45
Allocation
Not applicable
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-21

Among 1,051 studies in Dementia with a site in United States — 211 open to participants now, 276 under way, 15 of them phase 3. Dementia · United States.

Enrollment
572nd of 846
45 · median 93
Started
2022
with 87 others
No phase
562 of 1,051
118 open now
Registered
732nd of 1,051
by date

Among the 1,051 studies in Dementia with a site in United States, this one is the 572nd largest by enrollment of the 846 interventional ones that give a count, is one of 88 that started in 2022, is one of 562 with no phase, and was the 732nd registered.

Dementia

2,377 studies on the registry are indexed under Dementia; 572 are open to participants now.

Browse Dementia studies →

Open to participants now

211 of the 1,051 studies in Dementia with a site in United States are open now. Recruiting first, the newest first:

206 more — sign in →

All 211 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 382 Dementia studies recruiting now, 242 (63%) set no upper age limit and 25 (7%) stop at 75 or younger; 15 take children under 18; 163 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 1,051 studies in Dementia with a site in United States, or all of them as a file.
02

Study summary

This study will involve testing of an Alpha version of an app called "Building Relationships using Artificial Intelligence and Nostalgia" or BRAIN. The BRAIN App will be the first -ever artificial intelligence infused CST app for PWD. The app has two main goals: (1) to foster positive relationships between the care triad, and (2) to promote QoL while reducing responsive behaviors in PWD. Testing will examine the app's impact on engagement/affect for both PWD and professional Care Partners.

Read the detailed description

A quasi-experimental pretest / posttest design will be used. During a four-week baseline period, researchers will collect data on engagement, quality of life, neuropsychiatric symptoms, and quality of the care-patient relationship. Participants will then use the BRAIN app for four weeks, during which engagement data will be collect. After the intervention period, researchers will collect data again on quality of life, neuropsychiatric symptoms, and quality of the carer-patient relationship.

03

Conditions studied

  • Dementia
  • Dementia, Vascular
  • Alzheimer Disease
  • Dementia, Mixed

Keywords

  • psychosocial
  • non-pharmacological
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Eligibility criteria

PWD Inclusion Criteria:

  • diagnosed with dementia (any type)
  • resident in ALF or NH
  • 65+ years old
  • read and speak English
  • exhibit at least one responsive behavior on the NPI-NH or score below maximum score on the DEMQOL

PWD Exclusion Criteria:

  • bed-confined
  • completely unable to communicate verbally
  • have serious visual or hearing impairments
  • show signs of rapid decline or over the last six months

Staff and Family Member Inclusion Criteria

  • 18+ years old
  • speak and read English

Staff and Family Member Exclusion Criteria

-n/a

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
45 participants (actual)

Study arms

  • Experimental
    Treatment

    BRAIN Intervention

    Behavioral: The BRAIN App

Interventions

  • BehavioralThe BRAIN App

    The BRAIN App will be the first-ever artificial intelligence enabled cognitive stimulation therapy app, specifically designed for PWD. The goal of the app is to foster positive relationships between the care triad.

06

What researchers measure

Primary outcomes

  1. Change From Baseline to Treatment for Constructive Engagement on the Menorah Park Engagement Scale

    Constructive Engagement on the Menorah Park Engagement Scale is defined as doing or commenting on something related to the target activity. During baseline, multiple observations of "standard" activities were observed and a mean was calculated. Then, again, during treatment, multiple BRAIN activities were observed and a mean was calculated. The minimum value for Constructive Engagement is zero (0) and the maximum score is two (2). Higher scores represent a better outcome.

    Time frame: Baseline (Weeks 1-4) and Treatment (Weeks 5-10)

  2. Change From Baseline to Treatment for Passive Engagement on the Menorah Park Engagement Scale

    Passive Engagement on the Menorah Park Engagement Scale is defined as listening or watching something related to the target activity. During baseline, multiple observations of "standard" activities were observed and a mean was calculated. Then, again, during treatment, multiple BRAIN activities were observed and a mean was calculated. The minimum value for Passive Engagement is zero (0) and the maximum score is two (2). Lower scores represent a better outcome.

    Time frame: Baseline (Weeks 1-4) and Treatment (Weeks 5-10)

  3. Change From Baseline to Treatment for Other Engagement on the Menorah Park Engagement Scale

    Other Engagement on the Menorah Park Engagement Scale is defined as doing, commenting, listening, or watching something NOT related to the target activity. During baseline, multiple observations of "standard" activities were observed and a mean was calculated. Then, again, during treatment, multiple BRAIN activities were observed and a mean was calculated. The minimum value for Other Engagement is zero (0) and the maximum score is two (2). Lower scores represent a better outcome.

    Time frame: Baseline (Weeks 1-4) and Treatment (Weeks 5-10)

  4. Change From Baseline to Treatment for Non-Engagement on the Menorah Park Engagement Scale

    Non-Engagement on the Menorah Park Engagement Scale is defined as sleeping and/or staring into space. During baseline, multiple observations of "standard" activities were observed and a mean was calculated. Then, again, during treatment, multiple BRAIN activities were observed and a mean was calculated. The minimum value for Non-Engagement is zero (0) and the maximum score is two (2). Lower scores represent a better outcome.

    Time frame: Baseline (Weeks 1-4) and Treatment (Weeks 5-10)

  5. Change From Baseline to Treatment for Pleasure on the Menorah Park Engagement Scale

    Pleasure on the Menorah Park Engagement Scale is defined as clearly observable laughing or smiling. During baseline, multiple observations of "standard" activities were observed and a mean was calculated. Then, again, during treatment, multiple BRAIN activities were observed and a mean was calculated. The minimum value for Pleasure is zero (0) and the maximum score is two (2). Lower scores represent a better outcome.

    Time frame: Baseline (Weeks 1-4) and Treatment (Weeks 5-10)

  6. Change From Baseline to Treatment for Positive Items Sub-score on the Engagement of Persons With Dementia Scale (EPWDS)

    The Positive Items Sub-score on the EPWDS is the total score for the five following items: (1) Displays positive affect, (2) maintains eye contact, (3) Initiates, participates, or maintains verbal conversation, sounds or gestures (e.g., nodding) in response to the activity, or the materials used, or the person/s involved, (4) Responds to an activity by approaching, reaching out, touching, holding or handling the activity, the material used, or the person/s involved, and (5) Uses the activity or the material/s to encourage others to interact, or as a communication channel to interact and talk with others (e.g., staff and other residents). During baseline, multiple observations of "standard" activities were observed and a mean was calculated for the positive item sub-score. Then, again, during treatment, multiple BRAIN activities were observed and a mean was calculated. The minimum value is 0 and the maximum score is 20. Higher scores represent a better outcome.

    Time frame: Baseline (Weeks 1-4) and Treatment (Weeks 5-10)

  7. Change From Baseline to Treatment for Negative Items Sub-score on the Engagement of Persons With Dementia Scale (EPWDS)

    The Negative Items Sub-score on the EPWDS is the total score for the five following items: (1) Displays negative affect, (2) Appears inattentive, has an unfocused stare or turns head/eyes away from the activity, materials used, or the person/s involved, (3) Refuses to participate in the activity or in a conversation related to the activity by verbalizing e.g. "no", "stop", etc. OR verbalizes negative comment, complaint, and sound in response to or related to the activity, or the materials used, or the person/s involved, and (4) In response to the activity, is distracting or disrupting others (e.g., Staff/facilitator and other residents). During baseline, multiple observations of "standard" activities were observed and a mean was calculated for the negative item sub-score. Then, again, during treatment, multiple observations were taken and mean was calculate. Total score ranges from 0 to 16. Lower scores represent a better outcome.

    Time frame: Baseline (Weeks 1-4) and Treatment (Weeks 5-10)

Secondary outcomes

  1. Change From Baseline to Treatment on Dementia Related Quality of Life (DEMQOL)

    The Dementia Related Quality of Life Scale is a 28 item scale that examines quality of life in persons with dementia. The score ranges for 28 to 112. Higher scores represent a better outcome.

    Time frame: Baseline (Weeks 1-4) and Post-Treatment (Week 11)

  2. Change From Baseline to Treatment on the Neuropsychiatric Inventory-Nursing Home (NPI-NH), Frequency x Severity Score (FxS)

    The NPI-NH examines 10 types of neuropsychiatric symptoms in persons with dementia, with the FxS score looking creating a composite score that takes into account frequency and severity of the symtoms. The score ranges from 0 to 120. Lower scores represent a better outcome.

    Time frame: Baseline (Weeks 1-4) and Post-Treatment (Week 11)

  3. Change From Pre-Test to Post-Test for the Knowledge Assessment for BRAIN Training for Staff

    Staff took a quiz at pre-test and again at post-test. Scores range from 0 to 100, with higher scores representing a better outcome

    Time frame: Baseline (Week 1) and Post-Training (Week 5)

  4. Percent of Staff Who Thought Residents Enjoyed BRAIN Activities

    Staff were asked if they thought residents enjoyed using the BRAIN Activities. The total who said YES was converted into a percentage. Total score ranges from 0 to 100, with higher scores representing a better outcome.

    Time frame: Post-Treatment (Week 11)

  5. Percent of Staff Who Said They Would Recommend the BRAIN App to Colleagues

    Staff were asked if they would recommend BRAIN Activities to colleagues. The total who said YES was converted into a percentage. Total score ranges from 0 to 100, with higher scores representing a better outcome.

    Time frame: Post-Treatment (Week 11)

  6. Percent of Staff Who Said They Thought the BRAIN App Would Improve Quality of Life of Persons With Dementia.

    Staff were asked if they thought the BRAIN app would improve quality of life of persons with dementia.. The total who said YES was converted into a percentage. Total score ranges from 0 to 100, with higher scores representing a better outcome.

    Time frame: Post-Treatment (Week 11)

07

Results

Posted Mar 13, 2024

Participant flow

Baseline
Participant flow — Baseline
MilestonePersons With DementiaStaff MembersFamily Members
Started221310
Completed221310
Not completed000
Treatment
Participant flow — Treatment
MilestonePersons With DementiaStaff MembersFamily Members
Started22130
Completed22130
Not completed000
Post-Treatment
Participant flow — Post-Treatment
MilestonePersons With DementiaStaff MembersFamily Members
Started22130
Completed22130
Not completed000

Outcome measures

PrimaryChange From Baseline to Treatment for Constructive Engagement on the Menorah Park Engagement Scale

Constructive Engagement on the Menorah Park Engagement Scale is defined as doing or commenting on something related to the target activity. During baseline, multiple observations of "standard" activities were observed and a mean was calculated. Then, again, during treatment, multiple BRAIN activities were observed and a mean was calculated. The minimum value for Constructive Engagement is zero (0) and the maximum score is two (2). Higher scores represent a better outcome.

Time frame:
Baseline (Weeks 1-4) and Treatment (Weeks 5-10)
Reported as:
Mean · score on scale
Change From Baseline to Treatment for Constructive Engagement on the Menorah Park Engagement Scale
score on scalePersons With Dementia
Change From Baseline to Treatment for Constructive Engagement on the Menorah Park Engagement Scale.72 ± .48
Statistical analysis
  • Persons With Dementia · t-test, 2 sided · p = <0.01 · Median difference (final values): 0.72 · 95% CI .51 to .94
PrimaryChange From Baseline to Treatment for Passive Engagement on the Menorah Park Engagement Scale

Passive Engagement on the Menorah Park Engagement Scale is defined as listening or watching something related to the target activity. During baseline, multiple observations of "standard" activities were observed and a mean was calculated. Then, again, during treatment, multiple BRAIN activities were observed and a mean was calculated. The minimum value for Passive Engagement is zero (0) and the maximum score is two (2). Lower scores represent a better outcome.

Time frame:
Baseline (Weeks 1-4) and Treatment (Weeks 5-10)
Reported as:
Mean · score on scale
Change From Baseline to Treatment for Passive Engagement on the Menorah Park Engagement Scale
score on scalePersons With Dementia
Change From Baseline to Treatment for Passive Engagement on the Menorah Park Engagement Scale-0.33 ± .60
Statistical analysis
  • Persons With Dementia · t-test, 2 sided · p = .017 · Mean difference (final values): -.33 · 95% CI -0.59 to -0.07
PrimaryChange From Baseline to Treatment for Other Engagement on the Menorah Park Engagement Scale

Other Engagement on the Menorah Park Engagement Scale is defined as doing, commenting, listening, or watching something NOT related to the target activity. During baseline, multiple observations of "standard" activities were observed and a mean was calculated. Then, again, during treatment, multiple BRAIN activities were observed and a mean was calculated. The minimum value for Other Engagement is zero (0) and the maximum score is two (2). Lower scores represent a better outcome.

Time frame:
Baseline (Weeks 1-4) and Treatment (Weeks 5-10)
Reported as:
Mean · score on scale
Change From Baseline to Treatment for Other Engagement on the Menorah Park Engagement Scale
score on scalePersons With Dementia
Change From Baseline to Treatment for Other Engagement on the Menorah Park Engagement Scale-.25 ± .40
Statistical analysis
  • Persons With Dementia · t-test, 2 sided · p = .008 · Mean difference (final values): -.25 · 95% CI -0.43 to -0.07
PrimaryChange From Baseline to Treatment for Non-Engagement on the Menorah Park Engagement Scale

Non-Engagement on the Menorah Park Engagement Scale is defined as sleeping and/or staring into space. During baseline, multiple observations of "standard" activities were observed and a mean was calculated. Then, again, during treatment, multiple BRAIN activities were observed and a mean was calculated. The minimum value for Non-Engagement is zero (0) and the maximum score is two (2). Lower scores represent a better outcome.

Time frame:
Baseline (Weeks 1-4) and Treatment (Weeks 5-10)
Reported as:
Mean · score on scale
Change From Baseline to Treatment for Non-Engagement on the Menorah Park Engagement Scale
score on scalePersons With Dementia
Change From Baseline to Treatment for Non-Engagement on the Menorah Park Engagement Scale-0.15 ± .34
Statistical analysis
  • Persons With Dementia · t-test, 2 sided · p = 0.053 · Median difference (final values): -.15 · 95% CI -.30 to -.00
PrimaryChange From Baseline to Treatment for Pleasure on the Menorah Park Engagement Scale

Pleasure on the Menorah Park Engagement Scale is defined as clearly observable laughing or smiling. During baseline, multiple observations of "standard" activities were observed and a mean was calculated. Then, again, during treatment, multiple BRAIN activities were observed and a mean was calculated. The minimum value for Pleasure is zero (0) and the maximum score is two (2). Lower scores represent a better outcome.

Time frame:
Baseline (Weeks 1-4) and Treatment (Weeks 5-10)
Reported as:
Mean · score on scale
Change From Baseline to Treatment for Pleasure on the Menorah Park Engagement Scale
score on scalePersons With Dementia
Change From Baseline to Treatment for Pleasure on the Menorah Park Engagement Scale.66 ± .28
Statistical analysis
  • Persons With Dementia · t-test, 2 sided · p = <.01 · Mean difference (final values): .66 · 95% CI .54 to .79
PrimaryChange From Baseline to Treatment for Positive Items Sub-score on the Engagement of Persons With Dementia Scale (EPWDS)

The Positive Items Sub-score on the EPWDS is the total score for the five following items: (1) Displays positive affect, (2) maintains eye contact, (3) Initiates, participates, or maintains verbal conversation, sounds or gestures (e.g., nodding) in response to the activity, or the materials used, or the person/s involved, (4) Responds to an activity by approaching, reaching out, touching, holding or handling the activity, the material used, or the person/s involved, and (5) Uses the activity or the material/s to encourage others to interact, or as a communication channel to interact and talk with others (e.g., staff and other residents). During baseline, multiple observations of "standard" activities were observed and a mean was calculated for the positive item sub-score. Then, again, during treatment, multiple BRAIN activities were observed and a mean was calculated. The minimum value is 0 and the maximum score is 20. Higher scores represent a better outcome.

Time frame:
Baseline (Weeks 1-4) and Treatment (Weeks 5-10)
Reported as:
Mean · score on scale
Change From Baseline to Treatment for Positive Items Sub-score on the Engagement of Persons With Dementia Scale (EPWDS)
score on scalePersons With Dementia
Change From Baseline to Treatment for Positive Items Sub-score on the Engagement of Persons With Dementia Scale (EPWDS)4.11 ± 3.35
Statistical analysis
  • Persons With Dementia · t-test, 2 sided · p = <.001 · Mean difference (final values): 4.11 · 95% CI 2.62 to 5.60
PrimaryChange From Baseline to Treatment for Negative Items Sub-score on the Engagement of Persons With Dementia Scale (EPWDS)

The Negative Items Sub-score on the EPWDS is the total score for the five following items: (1) Displays negative affect, (2) Appears inattentive, has an unfocused stare or turns head/eyes away from the activity, materials used, or the person/s involved, (3) Refuses to participate in the activity or in a conversation related to the activity by verbalizing e.g. "no", "stop", etc. OR verbalizes negative comment, complaint, and sound in response to or related to the activity, or the materials used, or the person/s involved, and (4) In response to the activity, is distracting or disrupting others (e.g., Staff/facilitator and other residents). During baseline, multiple observations of "standard" activities were observed and a mean was calculated for the negative item sub-score. Then, again, during treatment, multiple observations were taken and mean was calculate. Total score ranges from 0 to 16. Lower scores represent a better outcome.

Time frame:
Baseline (Weeks 1-4) and Treatment (Weeks 5-10)
Reported as:
Mean · score on scale
Change From Baseline to Treatment for Negative Items Sub-score on the Engagement of Persons With Dementia Scale (EPWDS)
score on scalePersons With Dementia
Change From Baseline to Treatment for Negative Items Sub-score on the Engagement of Persons With Dementia Scale (EPWDS)-1.07 ± 1.10
Statistical analysis
  • Persons With Dementia · t-test, 2 sided · p = <.001 · Mean difference (final values): -1.07 · 95% CI -1.55 to -0.58
SecondaryChange From Baseline to Treatment on Dementia Related Quality of Life (DEMQOL)

The Dementia Related Quality of Life Scale is a 28 item scale that examines quality of life in persons with dementia. The score ranges for 28 to 112. Higher scores represent a better outcome.

Time frame:
Baseline (Weeks 1-4) and Post-Treatment (Week 11)
Reported as:
Mean · score on scale
Change From Baseline to Treatment on Dementia Related Quality of Life (DEMQOL)
score on scalePersons With Dementia
Change From Baseline to Treatment on Dementia Related Quality of Life (DEMQOL)6.02 ± 11.4
Statistical analysis
  • Persons With Dementia · t-test, 2 sided · p = .022 · Median difference (final values): 6.02 · 95% CI 0.97 to 11.1
SecondaryChange From Baseline to Treatment on the Neuropsychiatric Inventory-Nursing Home (NPI-NH), Frequency x Severity Score (FxS)

The NPI-NH examines 10 types of neuropsychiatric symptoms in persons with dementia, with the FxS score looking creating a composite score that takes into account frequency and severity of the symtoms. The score ranges from 0 to 120. Lower scores represent a better outcome.

Time frame:
Baseline (Weeks 1-4) and Post-Treatment (Week 11)
Reported as:
Mean · score on scale
Change From Baseline to Treatment on the Neuropsychiatric Inventory-Nursing Home (NPI-NH), Frequency x Severity Score (FxS)
score on scalePersons With Dementia
Change From Baseline to Treatment on the Neuropsychiatric Inventory-Nursing Home (NPI-NH), Frequency x Severity Score (FxS)1.23 ± 9.5
Statistical analysis
  • Persons With Dementia · t-test, 2 sided · p = .551 · Mean difference (final values): 1.23 · 95% CI -2.90 to 5.44
SecondaryChange From Pre-Test to Post-Test for the Knowledge Assessment for BRAIN Training for Staff

Staff took a quiz at pre-test and again at post-test. Scores range from 0 to 100, with higher scores representing a better outcome

Time frame:
Baseline (Week 1) and Post-Training (Week 5)
Reported as:
Mean · percent score on quiz out of 100
Change From Pre-Test to Post-Test for the Knowledge Assessment for BRAIN Training for Staff
percent score on quiz out of 100Staff Members
Change From Pre-Test to Post-Test for the Knowledge Assessment for BRAIN Training for Staff27.43 ± .11
Statistical analysis
  • Staff Members · t-test, 2 sided · p = <.001 · Mean difference (final values): 27.43 · 95% CI 17.7 to 37.2
SecondaryPercent of Staff Who Thought Residents Enjoyed BRAIN Activities

Staff were asked if they thought residents enjoyed using the BRAIN Activities. The total who said YES was converted into a percentage. Total score ranges from 0 to 100, with higher scores representing a better outcome.

Time frame:
Post-Treatment (Week 11)
Reported as:
Number · percentage who said yes
Percent of Staff Who Thought Residents Enjoyed BRAIN Activities
percentage who said yesStaff Members
Percent of Staff Who Thought Residents Enjoyed BRAIN Activities100
SecondaryPercent of Staff Who Said They Would Recommend the BRAIN App to Colleagues

Staff were asked if they would recommend BRAIN Activities to colleagues. The total who said YES was converted into a percentage. Total score ranges from 0 to 100, with higher scores representing a better outcome.

Time frame:
Post-Treatment (Week 11)
Reported as:
Number · percentage who said yes
Percent of Staff Who Said They Would Recommend the BRAIN App to Colleagues
percentage who said yesStaff Members
Percent of Staff Who Said They Would Recommend the BRAIN App to Colleagues100
SecondaryPercent of Staff Who Said They Thought the BRAIN App Would Improve Quality of Life of Persons With Dementia.

Staff were asked if they thought the BRAIN app would improve quality of life of persons with dementia.. The total who said YES was converted into a percentage. Total score ranges from 0 to 100, with higher scores representing a better outcome.

Time frame:
Post-Treatment (Week 11)
Reported as:
Number · percentage who said yes
Percent of Staff Who Said They Thought the BRAIN App Would Improve Quality of Life of Persons With Dementia.
percentage who said yesStaff Members
Percent of Staff Who Said They Thought the BRAIN App Would Improve Quality of Life of Persons With Dementia.100

Adverse events

Collected over 5 months. Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Persons With Dementia0/22 (0%)0/22 (0%)0/22 (0%)
Staff Members———
Family Members———

Baseline characteristics

Age, Categorical
Age, Categorical(Participants)Persons With DementiaStaff MembersFamily MembersTotal
<=18 years0000
Between 18 and 65 years013619
>=65 years220426
Age, Continuous
Age, Continuous(years)Persons With DementiaStaff MembersFamily MembersTotal
Mean83.73 ± 6.5345.92 ± 11.6765.00 ± 11.168.6 ± 18.8
Sex: Female, Male
Sex: Female, Male(Participants)Persons With DementiaStaff MembersFamily MembersTotal
Female1413633
Male80412
Ethnicity (NIH/OMB)
Ethnicity (NIH/OMB)(Participants)Persons With DementiaStaff MembersFamily MembersTotal
Hispanic or Latino0101
Not Hispanic or Latino22121044
Unknown or Not Reported0000
Race (NIH/OMB)
Race (NIH/OMB)(Participants)Persons With DementiaStaff MembersFamily MembersTotal
American Indian or Alaska Native0000
Asian0000
Native Hawaiian or Other Pacific Islander0000
Black or African American6309
White16101036
More than one race0000
Unknown or Not Reported0000
Region of Enrollment
Region of Enrollment(participants)Persons With DementiaStaff MembersFamily MembersTotal
United States22131045
08

Study locations

1 site
  • The Hearthstone Institute
    Winchester, Massachusetts 01890, United States
09

References and documents

Study documents

PDFs hosted by the registry, ClinicalTrials.gov.

Individual participant data

Plan to share: No

10

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Jul 2022 to primary completion in Dec 2022, 5 months.

Results were first posted in Mar 2024, 1 year 2 months after primary completion.

Of 46 industry-sponsored interventional studies with no phase under Dementia, half reached primary completion within 17 months of starting (the median), counting those still running; a quarter within 11 and three quarters within 35. This study's 5 months is below that.

Counting every sponsor, half of 908 studies reached it within 25 months; a quarter within 11 and three quarters within 43.

How these figures are worked out, and which studies are left out of them.

Registered
Aug 10, 2022
First posted
Aug 25, 2022
StartActual
Jul 13, 2022
Primary completionActual
Dec 15, 2022
CompletionActual
Dec 31, 2022
Results first posted
Mar 13, 2024
Last update
Mar 13, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Mar 13, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT05515679
Lead sponsor
Hopeful Aging
Responsible party
Sponsor
First posted
Aug 25, 2022
Start date
Jul 13, 2022
Primary completion
Dec 15, 2022
Completion
Dec 31, 2022
Results posted
Mar 13, 2024
Last update
Mar 13, 2024

Study contacts

Michael Skrajner, MA
principal investigator · Hopeful Aging

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Feb 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion